{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panel Cefotaxime (0.015 - 8 mcg/ml)",
        "MicroScan MICroSTREP plus Panel"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K063101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021111"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "October 3, 2006",
    "Summary Letter Received Date": "October 10, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefotaxime"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci",
        "Streptococcus pneumoniae"
    ],
    "Specimen Container(s)": [
        "MicroScan MICroSTREP plus Panel"
    ],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Instrument read"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel with Cefotaxime instrument read capability for antimicrobial susceptibility testing of aerobic streptococci.",
    "Indications for Use Summary": "For determining quantitative and/or qualitative antimicrobial agent susceptibility of colonies grown on solid media of aerobic streptococci, including Streptococcus pneumoniae, with instrument read capability for Cefotaxime.",
    "fda_folder": "Microbiology"
}